GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » abrdn Life Sciences Investors (NYSE:HQL) » Definitions » Dividend Yield %

abrdn Life Sciences Investors (abrdn Life Sciences Investors) Dividend Yield % : 10.28% (As of Apr. 25, 2024)


View and export this data going back to . Start your Free Trial

What is abrdn Life Sciences Investors Dividend Yield %?

As of today (2024-04-25), the Trailing Annual Dividend Yield of abrdn Life Sciences Investors is 10.28%.

The historical rank and industry rank for abrdn Life Sciences Investors's Dividend Yield % or its related term are showing as below:

HQL' s Dividend Yield % Range Over the Past 10 Years
Min: 6.65   Med: 9.19   Max: 12.38
Current: 10.28

During the past 7 years, the highest Dividend Yield of abrdn Life Sciences Investors was 12.38%. The lowest was 6.65%. And the median was 9.19%.

HQL's Dividend Yield % is ranked better than
81.89% of 1215 companies
in the Asset Management industry
Industry Median: 5.63 vs HQL: 10.28

abrdn Life Sciences Investors's Dividend Payout Ratio for the six months ended in Sep. 2023 was 0.00.

Warning Sign:

If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of abrdn Life Sciences Investors is 1.62, which seems too high.

During the past 7 years, the highest Dividend Payout Ratio of abrdn Life Sciences Investors was 1.62. The lowest was 0.29. And the median was 0.63.

As of today (2024-04-25), the Forward Dividend Yield % of abrdn Life Sciences Investors is 10.28%.

abrdn Life Sciences Investors's Dividends per Share for the six months ended in Sep. 2023 was $0.64.

During the past 12 months, abrdn Life Sciences Investors's average Dividends Per Share Growth Rate was -12.90% per year. During the past 3 years, the average Dividends Per Share Growth Rate was -4.50% per year. During the past 5 years, the average Dividends Per Share Growth Rate was -3.20% per year.

During the past 7 years, the highest 3-Year average Dividends Per Share Growth Rate of abrdn Life Sciences Investors was 0.80% per year. The lowest was -4.50% per year. And the median was -1.50% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


abrdn Life Sciences Investors Dividend Yield % Historical Data

The historical data trend for abrdn Life Sciences Investors's Dividend Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

abrdn Life Sciences Investors Dividend Yield % Chart

abrdn Life Sciences Investors Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23
Dividend Yield %
Get a 7-Day Free Trial 9.87 8.36 8.03 10.76 10.26

abrdn Life Sciences Investors Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Dividend Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.03 9.98 10.76 9.33 10.26

Competitive Comparison of abrdn Life Sciences Investors's Dividend Yield %

For the Asset Management subindustry, abrdn Life Sciences Investors's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


abrdn Life Sciences Investors's Dividend Yield % Distribution in the Asset Management Industry

For the Asset Management industry and Financial Services sector, abrdn Life Sciences Investors's Dividend Yield % distribution charts can be found below:

* The bar in red indicates where abrdn Life Sciences Investors's Dividend Yield % falls into.



abrdn Life Sciences Investors Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

abrdn Life Sciences Investors Recent Full-Year* Dividend History

Amount Ex-date Record Date Pay Date Type Frequency Forex Rate
USD 0.3902024-02-212024-02-222024-03-28Cash DividendquarterlyUSD:USD 1.000000
USD 0.3002023-11-212023-11-222024-01-10Cash DividendquarterlyUSD:USD 1.000000
USD 0.3202023-08-242023-08-252023-09-29Cash DividendquarterlyUSD:USD 1.000000
USD 0.3202023-05-242023-05-252023-06-30Cash DividendquarterlyUSD:USD 1.000000

* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.

abrdn Life Sciences Investors's Trailing Annual Dividend Yield (%) for Today is calculated as

Trailing Annual Dividend Yield=Most Recent Full Year Dividend/Current Share Price
=1.33/12.95
=10.27 %

Current Share Price is $12.95.
abrdn Life Sciences Investors's Dividends per Share for the trailing twelve months (TTM) ended in Today is $1.33.

abrdn Life Sciences Investors's Forward Annual Dividend Yield (%) for Today is calculated as

Forward Annual Dividend Yield=Forward Full Year Dividend/Current Share Price
=1.56/12.95
=12.05 %

Current Share Price is $12.95.
abrdn Life Sciences Investors's Dividends per Share for the forward twelve months is calculated as $0.39 * 4 = $1.56.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


abrdn Life Sciences Investors  (NYSE:HQL) Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


abrdn Life Sciences Investors Dividend Yield % Related Terms

Thank you for viewing the detailed overview of abrdn Life Sciences Investors's Dividend Yield % provided by GuruFocus.com. Please click on the following links to see related term pages.


abrdn Life Sciences Investors (abrdn Life Sciences Investors) Business Description

Traded in Other Exchanges
N/A
Address
1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
abrdn Life Sciences Investors operates as a non-diversified closed-end management investment company. Its investment objective is to seek long-term capital appreciation by investing primarily in securities of Life Sciences companies. It invests in securities of public and private companies that are believed by the Fund's Investment Adviser, abrdn Inc to have significant potential for above-average growth.
Executives
Todd Reit director C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Bill Maher director 600 WEST BROADWAY, 30TH FL., SAN DIEGO CA 92101
Rose Dimartino director C/O ABRDN, 1900 MARKET STREET, PHILADELPHIA PA 19103
James Joseph O'connor other: Director of Adviser C/O ABERDEEN STANDARD INVESTMENTS, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Marika Tooze other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Aberdeen Standard Investments Inc. other: Adviser 1900 MARKET ST., 2ND FLOOR, PHILADELPHIA PA 19103
Jaclyn Marie Matsick other: Director of Adviser C/O ABRDN, 1900 MARKET STREET, SUITE 200, PHILADELPHIA PA 19103
Lucia Sitar officer: VP and Chief Legal Officer 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Jennifer A Nichols other: Director of Adviser 1735 MARKET STREET, 37TH FLOOR, PHILADELPHIA PA 19103
Christian Pittard officer: President ONE BOW CHURCHYARD, LONDON X0 EC4M 9HH
Megan Kennedy officer: Secretary and Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Sharon Ferrari officer: Treasurer and CFO 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Alan R Goodson officer: Vice President 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Joseph Andolina officer: Chief Compliance Officer & VP 1735 MARKET STREET, 32ND FLOOR, PHILADELPHIA PA 19103
Stephen Bird director 388 GREENWICH STREET, 17TH FLOOR, NEW YORK NY 10022

abrdn Life Sciences Investors (abrdn Life Sciences Investors) Headlines

From GuruFocus

Tekla Life Sciences Investors Declares Distribution

By Business Wire Business Wire 08-17-2021

Tekla Life Sciences Investors Paid Distribution

By Business Wire Business Wire 12-31-2021

Tekla Life Sciences Investors Paid Distribution

By Business Wire Business Wire 03-31-2023

Tekla Life Sciences Investors Declares Distribution

By Business Wire Business Wire 02-16-2021

Tekla Life Sciences Investors Paid Distribution

By Business Wire Business Wire 01-06-2021

Tekla Life Sciences Investors Declares Distribution

By Business Wire 08-15-2023

Tekla Life Sciences Investors Declares Distribution

By Business Wire Business Wire 11-16-2020

Tekla Life Sciences Investors Paid Distribution

By Business Wire 06-30-2023

Tekla Life Sciences Investors Declares Stock Distribution

By Business Wire Business Wire 08-17-2020